Patent details

92544 Product Name: Ezetimibe en combinaison avec rosuvastatine ou leurs sels pharmaceutiquement acceptées, y compris rosuvastatine sous forme de sel de zinc

Basic Information

Publication number:
92544
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP949285639
Legal Status:
Expired
Application number:
92544
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
2014120440, 2014120441, 2014120442
Marketing Authorization Type:
Marketing Authorization Date:
18/12/2014
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
13-9663, 13-9664, 13-9665
Marketing Authorization Type:
Marketing Authorization Date:
24/07/2014
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Norway (NO)

Dates

Filing date:
11/09/2014
First Marketing Authorization date:
24/07/2014
Grant date:
20/01/2015
Activation date:
14/09/2014
Publication date:
20/01/2015
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
14/09/2019
SPC Extension Expiration:
14/09/2019
Rejection date:
Withdrawal date:

Owner

From:
11/09/2014
 
 

Name:
MERCK SHARP & DOHME CORP.
Address:
EAST LINCOLN AVENUE 126, RAHWAY, NJ 07065, United States (US)

Agent

Name:
KIRKPATRICK SA / NV
From:
11/09/2014
Address:
AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
To:

Inventor

1

Name:
BURNETT Duane, A.
Address:
United States (US)

2

Name:
DUGAR Sundeep
Address:
United States (US)

3

Name:
MCKITTRICK Brian, A.
Address:
United States (US)

4

Name:
ROSENBLUM Stuart, B.
Address:
United States (US)

5

Name:
CLADER John, W.
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
09/07/2018
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages